An Evaluation of LY007 Cell Injection for r/r B-NHL

Conditions: B-NHL Interventions: Drug: LY007 Sponsors: Shanghai Longyao Biotechnology Inc., Ltd.; The First Affiliated Hospital with Nanjing Medical University; Ruijin Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials